OCULAR THERAPEUTIX, INC
OCULUnited States
58 filed reports · 386 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
58 reports · Jun 2014 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 20 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 37 | 3,815 | Jun 2014 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 12 | 3,894 | Dec 2014 to Dec 2025 |
| Current · 8-KSEC EDGAR | 9 | 20 | Dec 2019 to Jun 2023 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 3, 2026 | 261 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 5, 2026 | 152 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 5, 2026 | 668 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 4, 2025 | 180 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 5, 2025 | 104 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 5, 2025 | 106 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Mar 3, 2025 | 334 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 14, 2024 | 122 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 7, 2024 | 97 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 7, 2024 | 97 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Mar 11, 2024 | 331 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 7, 2023 | 124 | Open |
Financial data
386 concepts · 7,729 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial372 concepts · 7,520 facts · Dec 2012 to Jul 2026
- Net income loss69 · Dec 2012 to Jun 2026
- Operating income loss69 · Dec 2012 to Jun 2026
- Cash and cash equivalents at carrying value68 · Dec 2012 to Jun 2026
- General and administrative expense (US GAAP)68 · Dec 2012 to Jun 2026
- Nonoperating income expense68 · Dec 2012 to Jun 2026
- Research and development expense68 · Dec 2012 to Jun 2026
- Selling and marketing expense (US GAAP)68 · Dec 2012 to Jun 2026
- Increase decrease in accounts payable66 · Dec 2012 to Jun 2026
- Increase decrease in accrued liabilities66 · Dec 2012 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets66 · Dec 2012 to Jun 2026
- Payments to acquire property plant and equipment66 · Dec 2012 to Jun 2026
- Proceeds from stock options exercised66 · Dec 2012 to Jun 2026
- Share based compensation66 · Dec 2012 to Jun 2026
- Amortization of financing costs65 · Dec 2012 to Jun 2026
- Capital expenditures incurred but not yet paid65 · Sep 2013 to Jun 2026
- Investment income net65 · Dec 2012 to Jun 2026
- Stockholders equity (US GAAP)65 · Dec 2012 to Jun 2026
- Depreciation depletion and amortization64 · Dec 2012 to Jun 2026
- Increase decrease in accounts receivable64 · Dec 2013 to Jun 2026
- Revenue64 · Dec 2012 to Jun 2026
- Accounts payable current63 · Dec 2013 to Jun 2026
- Accrued liabilities current63 · Dec 2013 to Jun 2026
- Assets63 · Dec 2013 to Jun 2026
- Assets current63 · Dec 2013 to Jun 2026
Segment10 concepts · 118 facts · Dec 2022 to Jun 2026
- Allocated share based compensation expense14 · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)14 · Dec 2022 to Jun 2026
- Depreciation depletion and amortization14 · Dec 2022 to Jun 2026
- Interest expense nonoperating14 · Dec 2022 to Jun 2026
- Investment income net14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Revenue14 · Dec 2022 to Jun 2026
- Single Reportable Segment14 · Dec 2022 to Jun 2026
- Gains losses on extinguishment of debt3 · Mar 2024 to Sep 2024
- Single reportable segment3 · Dec 2023 to Dec 2025
Product2 concepts · 71 facts · Dec 2016 to Jun 2026
- Revenue60 · Dec 2016 to Jun 2026
- Cost of revenue (US GAAP)11 · Dec 2016 to Dec 2018
Guidance2 concepts · 20 facts · Mar 2020 to Aug 2023
- Revenue Guidance18 · Mar 2020 to Aug 2023
- Revenue Growth Guidance2 · Nov 2022
Segments
189 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 118 facts
- Single Reportable118 · Dec 2022 to Jun 2026
Product or servicesrt:ProductOrServiceAxis2 members · 48 facts
- Product28 · Dec 2020 to Jun 2026
- Collaboration Revenue20 · Mar 2022 to Dec 2025
Product or serviceus-gaap:ProductOrServiceAxis2 members · 23 facts
- Product22 · Dec 2016 to Dec 2018
- Collaboration Revenue1 · Dec 2016
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.